Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415154 · ClinicalTrials.gov registry record · NA
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A NA study, sponsored by Neuronetics.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT01415154 is a NA study that has completed, run by Neuronetics. The registered enrollment target is 67 participants.
The verdict
NCT01415154, a NA study, has completed, sponsored by Neuronetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of scheduled maintenance Transcranial Magnetic Stimulation (TMS) treatment compared to on-demand TMS treatment for symptomatic worsening in patients who have shown a clinical response to acute TMS treatment.
Interventions
- DEVICE NeuroStar TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01415154
The ClinicalTrials.gov registry entry for NCT01415154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroStar TMS is the first listed.
NCT01415154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01415154 about?
NCT01415154 is a clinical study titled "Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder". The purpose of this study is to evaluate the efficacy of scheduled maintenance Transcranial Magnetic Stimulation (TMS) treatment compared to on-demand TMS treatment for symptomatic worsening in patients who have shown a clinical response to acute TMS treatment.
What is the current status of trial NCT01415154?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2011-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01415154?
The interventions under investigation include: NeuroStar TMS (DEVICE).
Who is sponsoring clinical trial NCT01415154?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.